Literature DB >> 11156337

Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population.

W M Janssen1, H Hillege, S J Pinto-Sietsma, A A Bak, D De Zeeuw, P E de Jong.   

Abstract

Microalbuminuria is associated with both an increased prevalence of cardiovascular risk factors and greater renal and cardiovascular morbidity. We questioned whether in the general population such associations can be found at lower levels of urinary albumin excretion than that of classically defined microalbuminuria. To that purpose urinary albumin concentration was measured in 40619 subjects aged 28 to 75 years. The subjects filled in a questionnaire on cardiovascular risk factors and events and were divided in deciles according to their urinary albumin concentration. Smoking was associated with albuminuria in the fifth or higher decile of urinary albumin concentration, that is with an albumin concentration of 5.1 mg/l and higher. The lower cut-off point for a positive association with hypertension was 8.8 mg/l, and for diabetes 11.2 mg/l. Family history for cardiovascular disease and hyperlipidaemia were not associated with albuminuria. We conclude that urinary albumin concentrations far below the microalbuminuric range are associated with increased prevalence of established cardiovascular risk factors. Family history for cardiovascular disease and hyperlipidaemia seems to behave differently. These data emphasize the need for more studies on the impact of albuminuria on the prediction of cardiovascular and renal disease in the general population.

Entities:  

Mesh:

Year:  2000        PMID: 11156337     DOI: 10.1515/CCLM.2000.165

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

1.  Extended prognostic value of urinary albumin excretion for cardiovascular events.

Authors:  Auke H Brantsma; Stephan J L Bakker; Dick de Zeeuw; Paul E de Jong; Ronald T Gansevoort
Journal:  J Am Soc Nephrol       Date:  2008-06-04       Impact factor: 10.121

2.  Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort.

Authors:  Biniyam G Demissei; Douwe Postmus; Mattia A Valente; Pim van der Harst; Wijk H van Gilst; Edwin R Van den Heuvel; Hans L Hillege
Journal:  Eur J Epidemiol       Date:  2014-11-07       Impact factor: 8.082

3.  Predictors of incident albuminuria in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ashish Upadhyay; James B Meigs; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

4.  Alterations in cefalosporin levels in the serum and mandible of hyperlipaedemic rats after co-administration of ibuprofen.

Authors:  E Tsivou; I Melakopoulos; A Kotsiou; S Anagnostopoulou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

5.  Cigarette smoking, proteinuria, and renal function in middle-aged Japanese men from an occupational population.

Authors:  Yuka Noborisaka; Masao Ishizaki; Minori Nakata; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2011-08-24       Impact factor: 3.674

6.  Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.

Authors:  David G Warnock; Paul Muntner; Peter A McCullough; Xiao Zhang; Leslie A McClure; Neil Zakai; Mary Cushman; Britt B Newsome; Reshma Kewalramani; Michael W Steffes; George Howard; William M McClellan
Journal:  Am J Kidney Dis       Date:  2010-08-08       Impact factor: 8.860

7.  Evaluation of Serum Cyclooxygenase, Hepcidin Levels in Acute Renal Injury (AKI) Patients Following Cardiac Catheterization.

Authors:  Hind Fawzi Aref; Nazar Ahmed Naji; Hadaf Dhafir Ibrahim
Journal:  Rep Biochem Mol Biol       Date:  2021-07

8.  Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.

Authors:  Charlotte A Keyzer; Hiddo J Lambers-Heerspink; Michel M Joosten; Petronella E Deetman; Ron T Gansevoort; Gerjan Navis; Ido P Kema; Dick de Zeeuw; Stephan J L Bakker; Martin H de Borst
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 8.237

9.  Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis.

Authors:  Jaimon T Kelly; Guobin Su; Xindong Qin; Skye Marshall; Ailema González-Ortiz; Catherine M Clase; Katrina L Campbell; Hong Xu; Juan-Jesus Carrero
Journal:  J Am Soc Nephrol       Date:  2020-08-31       Impact factor: 10.121

10.  Smoking and chronic kidney disease in healthy populations.

Authors:  Yuka Noborisaka
Journal:  Nephrourol Mon       Date:  2012-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.